Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
VALID Act of 2023
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to clinical trials at the National Cancer Institute H.R.2369,VALID Act of 2023
VALID Act of 2023
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to clinical trials at the National Cancer Institute H.R.2369,VALID Act of 2023 U.S. Preventive Services Task Force (USPSTF) Guidelines
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2026 · first_quarter · 1A
Issues related to medical device supply chain Issues related to international trade
Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to preventative screenings Issues related to maternal health Issues related to women's health Issues related to diagnostic testing
Source: Senate LDA
PREVENT HPV Cancers Act of 2023
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to clinical trials at the National Cancer Institute U.S. Preventive Services Task Force (USPSTF) Guidelines H.R.3633, PREVENT HPV Cancers Act of 2023
PREVENT HPV Cancers Act of 2023
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to clinical trials at the National Cancer Institute U.S. Preventive Services Task Force (USPSTF) Guidelines H.R.3633, PREVENT HPV Cancers Act of 2023 H.R.4261, ARC Act of 2023
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to clinical trials at the National Cancer Institute U.S. Preventive Services Task Force (USPSTF) Guidelines H.R.3633, PREVENT HPV Cancers Act of 2023 H.R.4261, ARC Act of 2023
VALID Act of 2023
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency H.R.2369, VALID Act of 2023
VALID Act of 2023
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency H.R.2369, VALID Act of 2023
VALID Act of 2023
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to influenza H.R.2369, VALID Act of 2023
VALID Act of 2023
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency H.R.2369, VALID Act of 2023
Triple A Study Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2290, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act H.R.2631, Amputation Reduction and Compassion Act Issues related to chronic disease
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2290, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act H.R.2631, Amputation Reduction and Compassion Act Issues related to chronic disease
VALID Act of 2021
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2209, VALID Act of 2021 Issues related to Hernia awareness Issues related to Oncology
VALID Act of 2021
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency H.R.4128, VALID Act of 2021 S.2209, VALID Act of 2021
VALID Act of 2021
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2209, VALID Act of 2021 Issues related to Hernia awareness Issues related to Oncology
VALID Act of 2021
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2290, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act H.R.2631, Amputation Reduction and Compassion Act Issues related to chronic disease
To amend the Families First Coronavirus Response Act to extend child nutrition waiver authority, and for other purposes.
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2290, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act H.R.2631, Amputation Reduction and Compassion Act Issues related to chronic disease
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2209, VALID Act of 2021 Issues related to Hernia awareness Issues related to Oncology
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2209, VALID Act of 2021 Issues related to Hernia awareness Issues related to Oncology
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency H.R.4128, VALID Act of 2021 S.2209, VALID Act of 2021
Data Broker List Act of 2021
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2290, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act H.R.2631, Amputation Reduction and Compassion Act Issues related to chronic disease
Triple A Study Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers Issues related to diagnostic testing Issues related to legal reform Issues related to data privacy H.R.2631, ARC Act of 2021 H.R.4128, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act S.4760, PASTEUR Act
Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers Issues related to diagnostic testing Issues related to legal reform Issues related to data privacy H.R.2631, ARC Act of 2021 H.R.4128, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act S.4760, PASTEUR Act
Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers Issues related to antimicrobial stewardship Issues related to diagnostic testing H.R.2631, ARC Act of 2021 H.R.4128, VALID Act of 2021
VALID Act of 2021
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers Issues related to diagnostic testing Issues related to legal reform Issues related to data privacy H.R.2631, ARC Act of 2021 H.R.4128, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act S.4760, PASTEUR Act
VALID Act of 2021
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.4760, PASTEUR Act
VALID Act of 2021
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers Issues related to antimicrobial stewardship Issues related to diagnostic testing H.R.2631, ARC Act of 2021 H.R.4128, VALID Act of 2021
To amend the Families First Coronavirus Response Act to extend child nutrition waiver authority, and for other purposes.
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers Issues related to diagnostic testing Issues related to legal reform Issues related to data privacy H.R.2631, ARC Act of 2021 H.R.4128, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act S.4760, PASTEUR Act
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.4760, PASTEUR Act
Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers Issues related to diagnostic testing Issues related to legal reform Issues related to data privacy H.R.2631, ARC Act of 2021 H.R.4128, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act S.4760, PASTEUR Act
To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes.
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.748, CARES Act H.R.2064, Sunshine for Samples Act of 2019 H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 S.3404, VALID Act of 2020 Issues related to medication safety Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response
DISARM Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.748, CARES Act H.R.2064, Sunshine for Samples Act of 2019 H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 S.3404, VALID Act of 2020 Issues related to medication safety Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response
DISARM Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 H.R.6102, VALID Act of 2020 Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act Issues related to medical device supply chains
DISARM Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act Issues related to medical device supply chains Issues related to community health centers Issues related to health legal reform
DISARM Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 H.R.6102, VALID Act of 2020 Issues related to medication safety Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act
VALID Act of 2020
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 H.R.6102, VALID Act of 2020 Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act Issues related to medical device supply chains
VALID Act of 2020
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 H.R.6102, VALID Act of 2020 Issues related to medication safety Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act
H.R.748, CARES Act H.R.2064, Sunshine for Samples Act of 2019 H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 S.3404, VALID Act of 2020 Issues related to medication safety Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response
H.R.748, CARES Act H.R.2064, Sunshine for Samples Act of 2019 H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 S.3404, VALID Act of 2020 Issues related to medication safety Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response
To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes.
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.2064, Sunshine for Samples Act of 2019 H.R.3129, Jeanette Acosta Invest in Women's Health Act of 2019 Issues related to medication safety Issues related to device cyber security Issues related to medical device sterilization Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to end-stage renal disease devices Issues related to data privacy
To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes.
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.2064, Sunshine for Samples Act of 2019 H.R.3129, Jeanette Acosta Invest in Women's Health Act of 2019 Issues related to hazardous drug safety Issues related to medication safety and drug diversion Issues related to device cyber security Issues related to medical device sterilization Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to end-stage renal disease devices Issues related to data privacy
To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes.
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.2064, Sunshine for Samples Act of 2019 H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 Issues related to medication safety Issues related to medical device sterilization Issues related to medical technology regulation Issues related to end-stage renal disease devices Issues related to data privacy
Protect Medical Innovation Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.2207, Protect Medical Innovation Act of 2019, repeal of the medical device tax S.692, Protect Medical Innovation Act of 2019, repeal of the medical device tax
Protect Medical Innovation Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.2207, Protect Medical Innovation Act of 2019, repeal of the medical device tax S.692, Protect Medical Innovation Act of 2019, repeal of the medical device tax
Protect Medical Innovation Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.2207, Protect Medical Innovation Act of 2019, repeal of the medical device tax S.692, Protect Medical Innovation Act of 2019, repeal of the medical device tax
Protect Medical Innovation Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.2207, Protect Medical Innovation Act of 2019, repeal of the medical device tax S.692, Protect Medical Innovation Act of 2019, repeal of the medical device tax
Jeanette Acosta Invest in Women’s Health Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.2064, Sunshine for Samples Act of 2019 H.R.3129, Jeanette Acosta Invest in Women's Health Act of 2019 Issues related to hazardous drug safety Issues related to medication safety and drug diversion Issues related to device cyber security Issues related to medical device sterilization Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to end-stage renal disease devices Issues related to data privacy
Jeanette Acosta Invest in Women’s Health Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.2064, Sunshine for Samples Act of 2019 H.R.3129, Jeanette Acosta Invest in Women's Health Act of 2019 Issues related to medication safety Issues related to device cyber security Issues related to medical device sterilization Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to end-stage renal disease devices Issues related to data privacy
DISARM Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.2064, Sunshine for Samples Act of 2019 H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 Issues related to medication safety Issues related to medical device sterilization Issues related to medical technology regulation Issues related to end-stage renal disease devices Issues related to data privacy
Protect Medical Innovation Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.2207, Protect Medical Innovation Act of 2019, repeal of the medical device tax S.692, Protect Medical Innovation Act of 2019, repeal of the medical device tax
Protect Medical Innovation Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.2207, Protect Medical Innovation Act of 2019, repeal of the medical device tax S.692, Protect Medical Innovation Act of 2019, repeal of the medical device tax
Protect Medical Innovation Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.2207, Protect Medical Innovation Act of 2019, repeal of the medical device tax S.692, Protect Medical Innovation Act of 2019, repeal of the medical device tax
Protect Medical Innovation Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.2207, Protect Medical Innovation Act of 2019, repeal of the medical device tax S.692, Protect Medical Innovation Act of 2019, repeal of the medical device tax
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2017 H.R.1, Tax Cuts and Jobs Act
Protect Medical Innovation Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2017 H.R.1, Tax Cuts and Jobs Act
Protect Medical Innovation Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2017 S.108, Medical Device Access and Innovation Protection Act
Protect Medical Innovation Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2018 S.108, Medical Device Access and Innovation Protection Act
Protect Medical Innovation Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2017 S.108, Medical Device Access and Innovation Protection Act
FDA Reauthorization Act of 2017
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.2430, FDA Reauthorization Act of 2017 VA procurement Issues related to hazardous drug safety Issues related to medical technology regulation P.L.109-417 PAHPA Opioids
Veterans Affairs Medical-Surgical Purchasing Stabilization Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combatting Opioid Abuse for Care in Hospitals (COACH) Act of 2018 S.2680, The Opioid Response Act of 2018
Veterans Affairs Medical-Surgical Purchasing Stabilization Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combating Opioid Abuse for Care in Hospitals Act of 2018
Veterans Affairs Medical-Surgical Purchasing Stabilization Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act S.2248, Veterans Benefits and Transition Act of 2018 Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combatting Opioid Abuse for Care in Hospitals (COACH) Act of 2018 S.2680, The Opioid Response Act of 2018 Issues related to device cybersecurity
COACH Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combating Opioid Abuse for Care in Hospitals Act of 2018
COACH Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combatting Opioid Abuse for Care in Hospitals (COACH) Act of 2018 S.2680, The Opioid Response Act of 2018
COACH Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act S.2248, Veterans Benefits and Transition Act of 2018 Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combatting Opioid Abuse for Care in Hospitals (COACH) Act of 2018 S.2680, The Opioid Response Act of 2018 Issues related to device cybersecurity
Medical Device Access and Innovation Protection Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2018 S.108, Medical Device Access and Innovation Protection Act
Medical Device Access and Innovation Protection Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2017 S.108, Medical Device Access and Innovation Protection Act
Medical Device Access and Innovation Protection Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2017 S.108, Medical Device Access and Innovation Protection Act
Veterans Benefits and Transition Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act S.2248, Veterans Benefits and Transition Act of 2018 Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combatting Opioid Abuse for Care in Hospitals (COACH) Act of 2018 S.2680, The Opioid Response Act of 2018 Issues related to device cybersecurity
Opioid Crisis Response Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act S.2248, Veterans Benefits and Transition Act of 2018 Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combatting Opioid Abuse for Care in Hospitals (COACH) Act of 2018 S.2680, The Opioid Response Act of 2018 Issues related to device cybersecurity
Opioid Crisis Response Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combatting Opioid Abuse for Care in Hospitals (COACH) Act of 2018 S.2680, The Opioid Response Act of 2018
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combating Opioid Abuse for Care in Hospitals Act of 2018
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combatting Opioid Abuse for Care in Hospitals (COACH) Act of 2018 S.2680, The Opioid Response Act of 2018
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act S.2248, Veterans Benefits and Transition Act of 2018 Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combatting Opioid Abuse for Care in Hospitals (COACH) Act of 2018 S.2680, The Opioid Response Act of 2018 Issues related to device cybersecurity
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2017 H.R.1, Tax Cuts and Jobs Act, Issues related to corporate tax
American Health Care Act of 2017
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to hazardous drug safety Issues related to opioid safety H.R.1628, American Health Care Act of 2017
American Health Care Act of 2017
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to hazardous drug safety Issues related to opioid safety H.R.1628, American Health Care Act of 2017
Protect Medical Innovation Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2017 Issues related to corporate tax
Protect Medical Innovation Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2017 Issues related to corporate tax
Protect Medical Innovation Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2017 H.R.1, Tax Cuts and Jobs Act, Issues related to corporate tax
Protect Medical Innovation Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2017 Issues related to corporate tax
Protect Medical Innovation Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2017 Issues related to corporate tax
FDA Reauthorization Act of 2017
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance Clinical lab fee schedule H.R.2430, FDA Reauthorization Act of 2017 VA procurement Issues related to hazardous drug safety Issues related to medical technology regulation
FDA Reauthorization Act of 2017
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to hazardous drug safety H.R.2430, FDA Reauthorization Act of 2017, Medical device user fee agreement VA procurement
Protect Medical Innovation Act of 2015
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.160, Protect Medical Innovation Act of 2015, Issues related to medical device tax Issues related to corporate tax
Protect Medical Innovation Act of 2015
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.160, Protect Medical Innovation Act of 2015, Issues related to medical device tax Issues related to corporate tax
21st Century Cures Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to diagnostic regulation Issues related to device regulation H.R. 34, 21st Century Cures Act Issues related to hazardous drug safety Issues related to opioid safety
21st Century Cures Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to diagnostic regulation Issues related to device regulation H.R. 34, 21st Century Cures Act Issues related to hazardous drug safety Issues related to opioid safety
Protect Medical Innovation Act of 2015
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act H.R.160, Protect Medical Innovation Act of 2015
Protect Medical Innovation Act of 2015
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act H.R.160, Protect Medical Innovation Act of 2015
Protect Medical Innovation Act of 2015
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act, issues related to medical device tax H.R.160, Protect Medical Innovation Act of 2015, issues related to medical device tax
Protect Medical Innovation Act of 2015
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act H.R.160, Protect Medical Innovation Act of 2015
Protect Medical Innovation Act of 2015
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.160, Protect Medical Innovation Act of 2015 S.149, Medical Device Access and Innovation Protection Act Issues related to international tax
Protect Medical Innovation Act of 2015
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act, issues related to medical device tax H.R.160, Protect Medical Innovation Act of 2015, issues related to medical device tax
Strengthening Public Health Emergency Response Act of 2016
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.3299, Strengthening Public Health Emergency Response Act of 2015 S.2153, Provider Payment Sunshine Act Issues related to diagnostic regulation Issues related to drug shortages
Medical Device Access and Innovation Protection Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act H.R.160, Protect Medical Innovation Act of 2015
Medical Device Access and Innovation Protection Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.160, Protect Medical Innovation Act of 2015 S.149, Medical Device Access and Innovation Protection Act Issues related to international tax
Medical Device Access and Innovation Protection Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act, issues related to medical device tax H.R.160, Protect Medical Innovation Act of 2015, issues related to medical device tax
Medical Device Access and Innovation Protection Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act, issues related to medical device tax H.R.160, Protect Medical Innovation Act of 2015, issues related to medical device tax
Medical Device Access and Innovation Protection Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act H.R.160, Protect Medical Innovation Act of 2015
Medical Device Access and Innovation Protection Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act H.R.160, Protect Medical Innovation Act of 2015
Issues related to medical device supply chains and supply chain resiliency Issues related to medical research funding Issues related to medical device sterilization
Issues related to corporate taxation Tax incentives for domestic manufacturing
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS)
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2026 · third_quarter · Q3
Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to maternal health
Issues related to corporate taxation Tax incentives for domestic manufacturing
Issues related to reimbursement Issues related to CY2026 Home Health and DMEPOS PPS final rule and ANPRM on PPE and essential medicines
Issues related to international trade Issues related to medical device supply chain & Section 232 National Security Investigation into medical devices, and USMCA and Section 301 Investigations
Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to the National Defense Authorization Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2026 · second_quarter · Q2
Issues related to reimbursement Issues related to CY2026 Home Health and DMEPOS PPS final rule and ANPRM on PPE and essential medicines
Issues related to international trade Issues related to medical device supply chain & Section 232 National Security Investigation into medical devices, and USMCA and Section 301 Investigations
Issues related to corporate taxation Tax incentives for domestic manufacturing
Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to the National Defense Authorization Act
Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to maternal health
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2026 · first_quarter · Q1
Issues related to medical device supply chains and supply chain resiliency Issues related to medical research funding Issues related to medical device sterilization
Issues related to medical device supply chain Issues related to international trade
Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to preventative screenings Issues related to maternal health Issues related to women's health Issues related to diagnostic testing
Issues related to corporate taxation Tax incentives for domestic manufacturing
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS)
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2025 · fourth_quarter · Q4
Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to preventative screenings Issues related to maternal health Issues related to women's health Issues related to diagnostic testing
Issues related to corporate taxation Tax incentives for domestic manufacturing
Issues related to medical device supply chains and supply chain resiliency Issues related to medical research funding Issues related to medical device sterilization
Issues related to medical device supply chain Issues related to international trade
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS)
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2025 · third_quarter · Q3
Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to preventative screenings Issues related to maternal health Issues related to women's health Issues related to diagnostic testing
Issues related to medical device supply chain Issues related to international trade
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2025 · first_quarter · 1A
Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization
Issues related to medical device supply chain
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2025 · second_quarter · 2A
Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to preventative screenings Issues related to maternal health
Issues related to medical device supply chain
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2025 · second_quarter · Q2
Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to preventative screenings Issues related to maternal health
Issues related to medical device supply chain
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2025 · first_quarter · Q1
Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization
Issues related to medical device supply chain
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2024 · fourth_quarter · Q4
Issues related to medical device supply chain
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to clinical trials at the National Cancer Institute U.S. Preventive Services Task Force (USPSTF) Guidelines H.R.3633, PREVENT HPV Cancers Act of 2023 H.R.4261, ARC Act of 2023
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2024 · third_quarter · Q3
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to clinical trials at the National Cancer Institute U.S. Preventive Services Task Force (USPSTF) Guidelines H.R.3633, PREVENT HPV Cancers Act of 2023
Issues related to medical device supply chain
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2024 · second_quarter · Q2
Issues related to medical device supply chain
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to clinical trials at the National Cancer Institute H.R.2369,VALID Act of 2023 U.S. Preventive Services Task Force (USPSTF) Guidelines
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2024 · first_quarter · Q1
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to clinical trials at the National Cancer Institute H.R.2369,VALID Act of 2023
Issues related to medical device supply chain
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2023 · fourth_quarter · Q4
Issues related to medical device supply chain
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency H.R.2369, VALID Act of 2023
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2023 · third_quarter · Q3
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency H.R.2369, VALID Act of 2023
Isssues related to trade.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2023 · second_quarter · Q2
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency H.R.2369, VALID Act of 2023
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2023 · first_quarter · Q1
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to influenza H.R.2369, VALID Act of 2023
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2022 · fourth_quarter · Q4
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency H.R.4128, VALID Act of 2021 S.2209, VALID Act of 2021
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2022 · third_quarter · Q3
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2209, VALID Act of 2021 Issues related to Hernia awareness Issues related to Oncology
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2022 · second_quarter · Q2
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2209, VALID Act of 2021 Issues related to Hernia awareness Issues related to Oncology
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2022 · first_quarter · Q1
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2290, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act H.R.2631, Amputation Reduction and Compassion Act Issues related to chronic disease
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2021 · fourth_quarter · Q4
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.4760, PASTEUR Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2021 · third_quarter · Q3
Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers Issues related to diagnostic testing Issues related to legal reform Issues related to data privacy H.R.2631, ARC Act of 2021 H.R.4128, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act S.4760, PASTEUR Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2021 · second_quarter · Q2
Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers Issues related to antimicrobial stewardship Issues related to diagnostic testing H.R.2631, ARC Act of 2021 H.R.4128, VALID Act of 2021
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2021 · first_quarter · Q1
Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers Issues related to antimicrobial stewardship Issues related to Peripheral artery disease
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2020 · fourth_quarter · Q4
H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act Issues related to medical device supply chains Issues related to community health centers Issues related to health legal reform
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2020 · third_quarter · Q3
H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 H.R.6102, VALID Act of 2020 Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act Issues related to medical device supply chains
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2020 · second_quarter · Q2
H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 H.R.6102, VALID Act of 2020 Issues related to medication safety Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2020 · first_quarter · Q1
H.R.748, CARES Act H.R.2064, Sunshine for Samples Act of 2019 H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 S.3404, VALID Act of 2020 Issues related to medication safety Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2019 · fourth_quarter · Q4
H.R.2064, Sunshine for Samples Act of 2019 H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 Issues related to medication safety Issues related to medical device sterilization Issues related to medical technology regulation Issues related to end-stage renal disease devices Issues related to data privacy
H.R.2207, Protect Medical Innovation Act of 2019, repeal of the medical device tax S.692, Protect Medical Innovation Act of 2019, repeal of the medical device tax
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2019 · third_quarter · Q3
H.R.2064, Sunshine for Samples Act of 2019 H.R.3129, Jeanette Acosta Invest in Women's Health Act of 2019 Issues related to medication safety Issues related to device cyber security Issues related to medical device sterilization Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to end-stage renal disease devices Issues related to data privacy
H.R.2207, Protect Medical Innovation Act of 2019, repeal of the medical device tax S.692, Protect Medical Innovation Act of 2019, repeal of the medical device tax
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2019 · second_quarter · Q2
H.R.2064, Sunshine for Samples Act of 2019 H.R.3129, Jeanette Acosta Invest in Women's Health Act of 2019 Issues related to hazardous drug safety Issues related to medication safety and drug diversion Issues related to device cyber security Issues related to medical device sterilization Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to end-stage renal disease devices Issues related to data privacy
H.R.2207, Protect Medical Innovation Act of 2019, repeal of the medical device tax S.692, Protect Medical Innovation Act of 2019, repeal of the medical device tax
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2019 · first_quarter · Q1
H.R.2207, Protect Medical Innovation Act of 2019, repeal of the medical device tax S.692, Protect Medical Innovation Act of 2019, repeal of the medical device tax
Issues related to medication safety and drug diversion Issues related to device cyber security Issues related to Veterans Affairs procurement of medical devices Issues related to medical device sterilization Issues related to hazardous drug safety Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to end-stage renal disease devices
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2018 · fourth_quarter · Q4
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act S.2248, Veterans Benefits and Transition Act of 2018 Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combatting Opioid Abuse for Care in Hospitals (COACH) Act of 2018 S.2680, The Opioid Response Act of 2018 Issues related to device cybersecurity
H.R.184, Protect Medical Innovation Act of 2018 S.108, Medical Device Access and Innovation Protection Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2018 · third_quarter · Q3
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combatting Opioid Abuse for Care in Hospitals (COACH) Act of 2018 S.2680, The Opioid Response Act of 2018
H.R.184, Protect Medical Innovation Act of 2017 S.108, Medical Device Access and Innovation Protection Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2018 · second_quarter · Q2
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combating Opioid Abuse for Care in Hospitals Act of 2018
H.R.184, Protect Medical Innovation Act of 2017 S.108, Medical Device Access and Innovation Protection Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2018 · first_quarter · Q1
Issues related to antimicrobial resistance H.R.2430, FDA Reauthorization Act of 2017 VA procurement Issues related to hazardous drug safety Issues related to medical technology regulation P.L.109-417 PAHPA Opioids
H.R.184, Protect Medical Innovation Act of 2017 H.R.1, Tax Cuts and Jobs Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2017 · fourth_quarter · Q4
H.R.184, Protect Medical Innovation Act of 2017 H.R.1, Tax Cuts and Jobs Act, Issues related to corporate tax
Issues related to antimicrobial resistance Clinical lab fee schedule H.R.2430, FDA Reauthorization Act of 2017 VA procurement Issues related to hazardous drug safety Issues related to medical technology regulation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2017 · third_quarter · Q3
Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to hazardous drug safety H.R.2430, FDA Reauthorization Act of 2017, Medical device user fee agreement VA procurement
H.R.184, Protect Medical Innovation Act of 2017 Issues related to corporate tax
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2017 · first_quarter · 1A
Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to hazardous drug safety Issues related to opioid safety H.R.1628, American Health Care Act of 2017
H.R.184, Protect Medical Innovation Act of 2017 Issues related to corporate tax
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2017 · second_quarter · Q2
Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to hazardous drug safety
H.R.184, Protect Medical Innovation Act of 2017 Issues related to corporate tax
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2017 · first_quarter · Q1
Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to hazardous drug safety Issues related to opioid safety H.R.1628, American Health Care Act of 2017
H.R.184, Protect Medical Innovation Act of 2017 Issues related to corporate tax
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2016 · fourth_quarter · 4A
Issues related to diagnostic regulation Issues related to device regulation H.R. 34, 21st Century Cures Act Issues related to hazardous drug safety Issues related to opioid safety
Issues related to value-based purchasing Issues related to UDI on Medicare claim forms Issues related to Flow cytometry reimbursement Issues related to Conditions of Participation
H.R.160, Protect Medical Innovation Act of 2015, Issues related to medical device tax Issues related to corporate tax
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2016 · third_quarter · 3A
Diagnostics reimbursement Issues related to UDI on Medicare claim forms
Issues related to medical device tax Issues related to corporate tax
Issues related to diagnostic regulation Issues related to veteran's health care WHO Prequalification program Issues related to device regulation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2016 · second_quarter · 2A
Issues related to medical device tax Issues related to corporate tax
Issues related to diagnostic regulation Issues related to drug shortages Issues related to veteran's health care WHO Prequalification program Issues related to device regulation
Diagnostics reimbursement Issues related to UDI on medical claim forms
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2016 · fourth_quarter · Q4
H.R.160, Protect Medical Innovation Act of 2015, Issues related to medical device tax Issues related to corporate tax
Issues related to value-based purchasing Issues related to UDI on Medicare claim forms Issues related to Flow cytometry reimbursement Issues related to Conditions of Participation
Issues related to diagnostic regulation Issues related to device regulation H.R. 34, 21st Century Cures Act Issues related to hazardous drug safety Issues related to opioid safety
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2016 · third_quarter · Q3
Issues related to diagnostic regulation Issues related to veteran's health care WHO Prequalification program Issues related to device regulation
Issues related to medical device tax Issues related to corporate tax
Diagnostics reimbursement Issues related to UDI on Medicare claim forms
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2016 · second_quarter · Q2
Issues related to medical device tax Issues related to corporate tax
Issues related to diagnostic regulation Issues related to drug shortages Issues related to veteran's health care WHO Prequalification program Issues related to device regulation
Diagnostics reimbursement Issues related to UDI on medical claim forms
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2016 · first_quarter · Q1
Issues related to medical device tax repeal Issues related to international tax
Issues related to diagnostic regulation Bio-specimen regulatory issue Issues related to drug shortages Issues related to pandemic preparedness Issues related to Health IT
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2015 · fourth_quarter · Q4
H.R.3299, Strengthening Public Health Emergency Response Act of 2015 S.2153, Provider Payment Sunshine Act Issues related to diagnostic regulation Issues related to drug shortages
H.R.160, Protect Medical Innovation Act of 2015 S.149, Medical Device Access and Innovation Protection Act Issues related to international tax
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2015 · third_quarter · Q3
Issues related to Sharps disposal reimbursement Diagnostics reimbursement Issues related to UDI on medical claim forms
Issues related to diagnostic regulation Issues related to drug shortages Issues related to pandemic preparedness
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act H.R.160, Protect Medical Innovation Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2015 · second_quarter · 2A
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act H.R.160, Protect Medical Innovation Act of 2015
Issues related to SGR Issues related to Sharps disposal Clinical lab fee schedule reform
Issues related to medication safety Issues related to device and diagnostic regulation Issues related to safe handling of hazardous drugs Issues related to drug shortages Issues related to pandemic preparedness Issues related to laboratory developed tests (LDTs)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2015 · first_quarter · 1A
NIH Funding BARDA Funding
Issues related to medication safety Issues related to device and diagnostic regulation Issues related to generic drug regulation
Issues related to SGR Issues related to Medicaid
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2015 · second_quarter · Q2
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act H.R.160, Protect Medical Innovation Act of 2015
Issues related to SGR Issues related to Sharps disposal Clinical lab fee schedule reform
Issues related to medication safety Issues related to device and diagnostic regulation Issues related to safe handling of hazardous drugs Issues related to drug shortages Issues related to pandemic preparedness Issues related to laboratory developed tests (LDTs)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2015 · first_quarter · Q1
Issues related to medication safety Issues related to device and diagnostic regulation Issues related to generic drug regulation
Issues related to SGR Issues related to Medicaid
NIH Funding BARDA Funding
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act, issues related to medical device tax H.R.160, Protect Medical Innovation Act of 2015, issues related to medical device tax
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, Treasury, Dept of
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act, issues related to medical device tax H.R.160, Protect Medical Innovation Act of 2015, issues related to medical device tax
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, Treasury, Dept of